Meta-analysis of 43 studies found early-onset CRC has higher TP53 and SMAD4 mutation frequencies and lower APC and KRAS mutations, highlighting distinct molecular pathways in younger adults. (Cancers)
Younger Patients Show Higher TP53 and SMAD4 Mutations
The CRC Digest